Plumbagin-2-Methyljuglone-DataSheet-生命科学试剂-MedChemExpress_第1页
Plumbagin-2-Methyljuglone-DataSheet-生命科学试剂-MedChemExpress_第2页
Plumbagin-2-Methyljuglone-DataSheet-生命科学试剂-MedChemExpress_第3页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEPlumbaginCat. No.: HY-N1497CAS No.: 481-42-5Synonyms: 2-Methyljuglone分式: CHO分量: 188.18作靶点: Others作通路: Others储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 150 mg/mL (797.11 mM)H2O : 40% PE

2、G300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (13.29 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% corn oil1/2 Master of Small Molecules 您边的抑制剂师www.MedChemESolubility: 2.5 mg/mL (13.29 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Plumbagin (2-Methyljuglone)是从 Plumbago zeylanica L 中得到的萘醌类物质,具有抗肿瘤、抗增殖

3、活性1。体外研究 Plumbagin (0, 5, 10, and 15 M) induces apoptosis of prostate cancer cell lines, such as DU145, CWR22rv1and LNCaP, in a dose-dependent manner 1.Plumbagin (5, 20 M) obviously inhibits the invasion of PC3, DU145, and CWR22rv1 cells 1.Apoptosis Analysis 1Cell Line: DU145, CWR22rv1, LNCaP and RW

4、PE-1 cellsConcentration: 0, 5, 10, and 15 MIncubation Time: 24 hoursResult: Dose-dependently induced apoptosis of DU145, CWR22rv1 and LNCaP, but showed noeffect on RWPE-1 cells at up to 20 M.体内研究 Plumbagin (2 mg/kg, i.p., five days a week for 11 weeks) inhibits the growth of tumor in male athymic nu

5、demice 1.Plumbagin (2 mg/kg, i.p., five days a week for 11 weeks) inhibits expression of PKC, suppresses JAK-2 andStat3 phosphorylation, and activates Stat3, PCNA, VEGF and MMP-9 in mice 1.Animal Model: Male athymic nude mice bearing DU145 cells 1Dosage: 2 mg/kgAdministration: I.P. after 3 days post

6、 cell implantation, five days a week.Result: Delayed tumor growth by 3 weeks, and reduced tumor weight and volume in mice.REFERENCES1. Aziz MH, et al. Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res. 2008 Nov 1;68(21):9024-32.McePdfHeightCaution: Product has not been fully validated for medical applications.For research use only.Tel:

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论